A Study of DS-1471a In Subjects With Advanced Solid Tumors

NCT06074705 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated by the sponsor due to a business decision.

Conditions

Advanced Solid Tumor

Interventions

DRUG: DS-1471a

Sponsor

Daiichi Sankyo Co., Ltd.